According to Drugwatch®, a non-profit drug information network and organization, an estimated four million patients in the USA alone visit doctors annually due to adverse effects of prescription drugs. Hence, gene therapy that aligns with the natural human genetic...
In response to growing demand for viral vector contract development and manufacturing organization (CDMO) Brammer Bio (recently acquired by Thermo Fisher Scientific) is completing $100 million in capital expansion projects. Thermo Fischer Scientific’s Brammer Bio has...
Viral-based gene therapy product company FinVector has invested 25 million euros in the new medication, reported to be the world’s sixth gene therapy drug. Gene therapy refers to the delivery of nucleic acid (containing DNA) into a patient’s cells with the intent of...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
